AML EHA Update image

AML EHA Update

Can't make it to the event?
We send a recording to all registered participants of the event!
Aug 20, 2026
11:00AM - 12:00PM EDT
Online Event
Overview

Join HealthTree as we learn about the newest developments in AML presented at the European Hematology Association this year! Dr. Shivani Handa will discuss not only her research in Azacitidine and Venetoclax for older AML patients, but also AML clinical updates you will not want to miss!

 

Agenda
11:00 AM
Introduction
Eliza Prickett

Eliza introduces the agenda of the event and our featured speaker Dr. Shivani Handa

11:05 AM
Presentation
Dr. Shivani Handa

Dr. Handa shares the latest updated on AML

11:35 AM
Questions and Answers
Audience

Come with your questions and we'll answer them!

Speakers & Moderators
Healthtree contact Eliza Prickett

Eliza Prickett

Eliza joined HealthTree in March 2026 as the Leukemia Patient Health Education Manager. Prior to joining HealthTree, she completed a Master’s Degree in Public Health from Brigham Young University and worked with a variety of underserved populations in government and healthcare settings, including Americorps and Utah Health Department. When not in office, Eliza enjoys reading, writing and learning new things about the world.
Healthtree contact Dr. Shivani Handa

Dr. Shivani Handa

As a hematologist, Dr. Handa specialize in caring for patients with various blood cancers and disorders, such as leukemia, myelodysplastic syndromes and myeloproliferative neoplasms. Dr. Handa's scholarly work focuses on clinical research and drug development in patients with myeloid malignancies, with an emphasis on myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). As a member of Beat-AML and MPN research consortium, my colleagues and I strive to develop novel clinical trials. My research has been published in prestigious peer-reviewed journals, such as Blood, Blood Advances, Leukemia and JCO Precision Oncology.